Literature DB >> 33275933

Outcomes in Patients With Severe Chronic Lung Disease Undergoing Index Cardiac Operations.

Lauren V Huckaby1, Edgar Aranda-Michel1, Ibrahim Sultan1, Danny Chu1, Shangzhen Chen1, Floyd Thoma1, Arman Kilic2.   

Abstract

BACKGROUND: This study evaluated the impact of severe chronic lung disease on outcomes of index adult cardiac operations.
METHODS: A single-center, retrospective study of adult patients with severe chronic lung disease (as defined by The Society of Thoracic Surgeons) undergoing index cardiac operations between 2010 and 2018 was performed. Multivariable Cox regression and Kaplan-Meier analyses were used to evaluate survival.
RESULTS: Three hundred fifty-four patients (median age, 69 years; 32.77% women) were identified. Current smokers comprised 42.66% of the population, and 34.65% of patients required home oxygen. Median preoperative forced expiratory volume in 1 second was 48% of predicted (interquartile range, 41%-56%), and median diffusing capacity of the lungs for carbon monoxide was 78% of predicted (interquartile range, 55%-101%). Most patients underwent isolated coronary artery bypass (57.06%) or isolated aortic valve replacement (19.49%). Overall, 33 patients (9.07%) required a tracheostomy (median of 10 days from surgery) for a median of 49 days (interquartile range, 25-114) until decannulation. Preoperative home oxygen use was an independent predictor of 30-day (hazard ratio, 2.91; P = .030) and 1-year (hazard ratio, 2.12; P = .009) mortality. One-year and 5-year postoperative survival were 83.62% and 58.34%, respectively.
CONCLUSIONS: Although severe chronic lung disease is a predictor of mortality and morbidity after index cardiac operations, only 9% of patients required a tracheostomy, and most were alive at 5 years after surgery. Home oxygen use may serve as a further stratification tool in this higher risk subset; however the presence of severe chronic lung disease alone should not deter from surgery in otherwise reasonable surgical candidates.
Copyright © 2021 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 33275933      PMCID: PMC9098253          DOI: 10.1016/j.athoracsur.2020.11.009

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   5.102


  19 in total

1.  Outcomes and predictors of prolonged ventilation in patients undergoing elective coronary surgery.

Authors:  Hesham Z Saleh; Matthew Shaw; Omar Al-Rawi; Jonathan Yates; D Mark Pullan; John A C Chalmers; Brian M Fabri
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-04-11

2.  Postoperative and long-term outcome of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass grafting.

Authors:  Dimitrios C Angouras; Constantine E Anagnostopoulos; Themistocles P Chamogeorgakis; Chris K Rokkas; Daniel G Swistel; Cliff P Connery; Ioannis K Toumpoulis
Journal:  Ann Thorac Surg       Date:  2010-04       Impact factor: 4.330

3.  Risk factors for early hospital readmission after cardiac operations.

Authors:  V A Ferraris; S P Ferraris; R C Harmon; B D Evans
Journal:  J Thorac Cardiovasc Surg       Date:  2001-08       Impact factor: 5.209

4.  Deaths: Final Data for 2017.

Authors:  Kenneth D Kochanek; Sherry L Murphy; Jiaquan Xu; Elizabeth Arias
Journal:  Natl Vital Stat Rep       Date:  2019-06

5.  Does minimalist transfemoral transcatheter aortic valve replacement produce better survival in patients with severe chronic obstructive pulmonary disease?

Authors:  Jose F Condado; Moosa N Haider; Stamatios Lerakis; Patricia Keegan; Hope Caughron; Vinod H Thourani; Chandan Devireddy; Bradley Leshnower; Kreton Mavromatis; Eric L Sarin; James Stewart; Robert Guyton; Jessica Forcillo; Ateet Patel; Amy Simone; Peter C Block; Vasilis Babaliaros
Journal:  Catheter Cardiovasc Interv       Date:  2016-11-12       Impact factor: 2.692

6.  Impact of preoperative chronic lung disease on survival after surgical aortic valve replacement.

Authors:  Rebecca L Gunter; Patrick Kilgo; Robert A Guyton; Edward P Chen; John D Puskas; William A Cooper; Michael E Halkos; Omar M Lattouf; Vasilis Babaliaros; Richard Myung; Bradley Leshnower; Vinod H Thourani
Journal:  Ann Thorac Surg       Date:  2013-08-20       Impact factor: 4.330

7.  Chronic obstructive pulmonary disease--an independent risk factor for long-term cardiac and cardiovascular mortality in patients with ischemic heart disease.

Authors:  Kei Nishiyama; Takeshi Morimoto; Yutaka Furukawa; Yoshihisa Nakagawa; Natsuhiko Ehara; Ryouji Taniguchi; Neiko Ozasa; Naritatsu Saito; Kozo Hoshino; Masanao Touma; Toshihiro Tamura; Yoshisumi Haruna; Satoshi Shizuta; Takahiro Doi; Masanori Fukushima; Toru Kita; Takeshi Kimura
Journal:  Int J Cardiol       Date:  2009-04-14       Impact factor: 4.164

8.  Effectiveness of a perioperative pulmonary rehabilitation program following coronary artery bypass graft surgery in patients with and without COPD.

Authors:  Jui-O Chen; Jui-Fang Liu; Yu-Qi Liu; Yu-Mu Chen; Mei-Lien Tu; Hong-Ren Yu; Meng-Chih Lin; Chiu-Chu Lin; Shih-Feng Liu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-05-16

Review 9.  Strategies to prevent intraoperative lung injury during cardiopulmonary bypass.

Authors:  Efstratios E Apostolakis; Efstratios N Koletsis; Nikolaos G Baikoussis; Stavros N Siminelakis; Georgios S Papadopoulos
Journal:  J Cardiothorac Surg       Date:  2010-01-11       Impact factor: 1.637

10.  Pre-treatment before coronary artery bypass surgery improves post-operative outcomes in moderate chronic obstructive pulmonary disease patients.

Authors:  Bilgehan Savas Oz; Erkan Kaya; Gokhan Arslan; Kubilay Karabacak; Faruk Cingoz; Mehmet Arslan
Journal:  Cardiovasc J Afr       Date:  2013-06       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.